BioNTech SE (ETR:22UA)

BioNTech SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,185	9,762	11,664	13,875	1,693	1,210
Short-Term Investments	3,925	7,022	4,885	189.4	381.6	137.2
Cash & Short-Term Investments	14,110	16,784	16,549	14,065	2,074	1,347
Cash Growth	-9.94%	1.42%	17.66%	578.04%	53.95%	158.70%
Accounts Receivable	966.5	1,474	2,161	7,146	12,382	165.5
Other Receivables	60.5	50	179.1	0.4	0.4	0.9
Receivables	1,027	1,524	2,340	7,146	12,382	166.4
Inventory	254.4	283.3	357.7	439.6	502.5	64.1
Other Current Assets	234.3	212.7	280.9	271.9	113.4	89
Total Current Assets	15,626	18,804	19,527	21,922	15,072	1,667
Property, Plant & Equipment	1,268	1,183	971.6	821.1	520.4	326
Long-Term Investments	2,286	1,254	1,176	80.2	21.3	-
Goodwill	375.9	380.6	362.5	61.2	57.8	53.7
Other Intangible Assets	1,511	767.7	781.7	145.4	136.8	103.8
Long-Term Accounts Receivable	7.9	9.8	-	-	-	-
Long-Term Deferred Tax Assets	85.5	81.7	81.3	229.6	-	161.2
Other Long-Term Assets	22.6	49	105.8	19.6	22.2	7
Total Assets	21,182	22,530	23,006	23,279	15,831	2,319
Accounts Payable	443.8	426.7	354	204.1	160	102.3
Current Portion of Long-Term Debt	14.3	-	-	-	102	3
Current Portion of Leases	41.2	39.5	28.1	36	27.9	6.1
Current Income Taxes Payable	5.4	4.5	525.5	595.9	1,569	-
Current Unearned Revenue	294.5	294.9	353.3	77.1	186.1	391.6
Other Current Liabilities	735.3	1,758	809.6	2,038	1,437	103
Total Current Liabilities	1,535	2,523	2,071	2,951	3,482	606
Long-Term Debt	31.9	-	2.4	2.1	17.9	152.9
Long-Term Leases	205.6	214.7	188.6	174.1	153.7	78.1
Long-Term Unearned Revenue	182.9	183	398.5	48.4	9	71.9
Long-Term Deferred Tax Liabilities	44.1	42.4	39.7	6.2	66.7	0.2
Other Long-Term Liabilities	256.8	155.3	60.7	42.1	208.2	37.7
Total Liabilities	2,256	3,119	2,760	3,224	3,937	946.8
Common Stock	248.6	248.6	248.6	248.6	246.3	246.3
Retained Earnings	18,682	19,098	19,763	18,833	9,883	-409.6
Treasury Stock	-8.2	-8.6	-10.8	-5.3	-3.8	-4.8
Comprehensive Income & Other	4	73.1	244.8	979.3	1,768	1,540
Total Common Equity	18,927	19,411	20,246	20,056	11,894	1,372
Shareholders' Equity	18,927	19,411	20,246	20,056	11,894	1,372
Total Liabilities & Equity	21,182	22,530	23,006	23,279	15,831	2,319
Total Debt	293	254.2	219.1	212.2	301.5	240.1
Net Cash (Debt)	13,817	16,529	16,330	13,852	1,773	1,107
Net Cash Growth	-10.46%	1.22%	17.89%	681.38%	60.10%	147.93%
Net Cash Per Share	57.49	68.76	67.28	55.45	6.83	4.46
Filing Date Shares Outstanding	240.39	239.97	237.73	240.99	242.52	241.52
Total Common Shares Outstanding	240.39	239.97	237.73	243.22	242.52	241.52
Working Capital	14,091	16,280	17,457	18,971	11,591	1,061
Book Value Per Share	78.73	80.89	85.16	82.46	49.04	5.68
Tangible Book Value	17,040	18,263	19,102	19,849	11,699	1,214
Tangible Book Value Per Share	70.88	76.10	80.35	81.61	48.24	5.03
Land	-	369.4	235.4	217	104.1	61.3
Machinery	-	427.7	344.1	273	198.3	142.4
Construction In Progress	-	460.6	389.5	235.5	94.3	81.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.